Zoekresultaten - 6 results
Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative
transforming oncology, but challenges such as insufficient analytical sensitivity, difficult variant interpretation, suboptimal turnaround time, limited deployment flexibility, and high costs hinder its broader ...
Recovering radiotherapy services in England: Our plan for action
visibility in the public debate as chemotherapy and other cancer treatments. This briefing explores the main drivers of lengthening waiting times for radiotherapy and what action we need at a national and ...
Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study
studied by assessing changes in the trend of the time to first treatment for women 18 or older who were diagnosed and treated for breast cancer between 2017 and 2021. Methods An observational retrospective ...
Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol
from a health and an economic perspective. To improve cancer patient outcomes and lower society expenses, early diagnosis and timely treatment are essential. The recent COVID-19 crisis has disrupted the ...
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
Cervical Dysplasia Uterine Cervical Neoplasms Abstract: AIM: The Papilloplex high-risk human papillomavirus (hrHPV) test (Genefirst, Oxford, UK) is a single tube real-time HPV test which provides multiplex ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
Infections Real-Time Polymerase Chain Reaction Reproducibility of Results Sensitivity and Specificity Uterine Cervical Dysplasia Uterine Cervical Neoplasms Abstract: Human papillomavirus (HPV) assays used in ...